International Brachytherapy S.A. ( International Brachytherapy ) is a medical devices company . It is engaged in the design, development, marketing and distribution of radiotherapeutic implants. International Brachytherapy develops brachytherapy equipments for treating breast and prostrate cancer. The company distributes its products across Germany and the US. The company`s product portfolio consists of InterSource seeds, InterStrand implants, OptiSeed sources and cutting fixtures . Their radiotherapy implants are placed near or inside cancerous tissues and delivers a cell-killing dose to the tumors to control cancer. It operates through its subsidiaries in United States and the UK. The company is headquartered in Seneffe , Belgium.The company reported revenues of (Euro) EUR 19.37 million during the fiscal year ended December 2008, an increase of 100.33% over 2007. The operating profit of the company was EUR 2.40 million during the fiscal year 2008, whereas the company reported an operating loss of EUR 0.24 million during 2007. The net loss of the company was EUR 2.68 million during the fiscal year 2008, as compared to a net loss of EUR 8.62 million during 2007.